Clinical Trials Logo

Filter by:
NCT ID: NCT04816916 Terminated - Clinical trials for Hepatic Encephalopathy

Efficacy and Safety of AXA1665 in Cirrhotic Subjects With Prior Overt Hepatic Encephalopathy

EMMPOWER
Start date: June 29, 2021
Phase: Phase 2
Study type: Interventional

This is a global study to compare the effects of AXA1665, an orally active mixture of amino acids, compared to placebo, on cognitive and physical function, as well as the safety and tolerability of AXA1665.

NCT ID: NCT04797533 Terminated - Clinical trials for Psychiatric Disorder

Minebea: Inpatient Monitoring Activity Project (IMAP) (Pilot)

Start date: June 14, 2019
Phase: N/A
Study type: Interventional

Monitoring of Biologic Signals of Elderly Patients

NCT ID: NCT04795466 Terminated - Alzheimer Disease Clinical Trials

Study of the Efficacy and Safety of Various Anti-inflammatory Agents in Participants With Mild Cognitive Impairment or Mild Alzheimer's Disease

Start date: October 28, 2021
Phase: Phase 2
Study type: Interventional

The purpose of this platform study is to evaluate the effect of anti-inflammatory agents on cognition in early Alzheimer's disease. Additionally, the safety and tolerability of these anti-inflammatory agents and the effects on central and peripheral inflammation will be evaluated.

NCT ID: NCT04790916 Terminated - Clinical trials for Autoimmune Hepatitis

Effect of RO7049665 on the Time to Relapse Following Steroid Tapering in Participants With Autoimmune Hepatitis (AIH)

Start date: April 19, 2021
Phase: Phase 2
Study type: Interventional

The primary objective of the study is to evaluate the effect of RO7049665 on time to relapse following forced corticosteroid (CCS) tapering as measured by the hazard ratio between RO7049665 7.5 milligrams (mg) and placebo arm.

NCT ID: NCT04785365 Terminated - Melanoma Clinical Trials

Long-Term Follow-Up Study of Patients Receiving ATL001

Start date: June 1, 2022
Phase: Phase 2
Study type: Interventional

This is an Open-Label, Multi-Centre Phase II study to evaluate the long-term safety and clinical activity of ATL001, previously administered intravenously to patients in Study ATX-NS-001 (NCT04032847) or Study ATX-ME-001 (NCT03997474).

NCT ID: NCT04778397 Terminated - Clinical trials for Acute Myeloid Leukemia

Study of Magrolimab in Combination With Azacitidine Versus Physician's Choice of Venetoclax in Combination With Azacitidine or Intensive Chemotherapy in Patients With TP53 Mutant Acute Myeloid Leukemia That Have Not Been Treated

ENHANCE-2
Start date: July 1, 2021
Phase: Phase 3
Study type: Interventional

The goal of this clinical study is to compare the effectiveness of the study drugs, magrolimab in combination with azacitidine, versus venetoclax in combination with azacitidine in participants with previously untreated TP53 mutant acute myeloid leukemia (AML).

NCT ID: NCT04770246 Terminated - Clinical trials for Advanced or Metastatic Solid Tumors Irrespective of Gene Alterations

TAS-117 in Patients With Advanced Solid Tumors Harboring Germline PTEN Mutations

Start date: March 31, 2021
Phase: Phase 1
Study type: Interventional

The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and antitumor activity of TAS-117 in patients with advanced or metastatic solid tumors (excluding primary brain tumors) harboring germline PTEN inactivating mutations.

NCT ID: NCT04752917 Terminated - Anaesthesia Clinical Trials

Do Noise Cancelling Headphones Reduce Sedation Requirements in Primary Knee Arthoplasty

NOISE
Start date: March 20, 2019
Phase: N/A
Study type: Interventional

The study is a randomised trial of headphones with midazolam patient controlled sedation (intervention group) vs control group with no heaphones to compare sedation usage during knee replacement surgery under spinal. The trial is a pilot study of 20 cases

NCT ID: NCT04748393 Terminated - Clinical trials for Venous Thromboembolism

Risk, Predictors, Impact and Outcome of Anticoagulation-associated Abnormal Menstrual Bleeding

TEAM-VTE
Start date: September 1, 2018
Phase:
Study type: Observational

This study is an international, multicenter, academically sponsored, observational study, that focusses on fertile female patients with proven symptomatic deep vein thrombosis of the legs (DVT) or acute pulmonary embolism (PE). The incidence and severity of abnormal menstrual bleeding will be assessed for each menstrual period and correlated to quality of life. Causes of abnormal menstrual bleeding other than active anticoagulant treatment will be assessed. Treatment of abnormal menstrual bleeding (all within routine clinical care) will be evaluated for efficacy and safety.

NCT ID: NCT04747730 Terminated - Well-being Clinical Trials

Fostering Inmates' Well-being and Mental Health

Start date: August 1, 2019
Phase: N/A
Study type: Interventional

The objective of the project was to provide an assessment of the impact of Transcendental Meditation on prison inmates' well-being. To achieve this goal the investigators conducted a before-and-after study in Her Majesty's Prison Warren Hill (HMP) (England). Meditation is correlated with better self-regulation and is innovative because it fosters generalisable psychological processes that support cognitive, emotional and behavioural regulation, with self-regulation being an important factor behind a variety of outcomes. Unfortunately, the trial couldn't be completed as the investigators didn't manage to recruit a sufficient number of participants.